DE602005017626D1 - Antivirale verwendung von borinsäurekomplexen - Google Patents

Antivirale verwendung von borinsäurekomplexen

Info

Publication number
DE602005017626D1
DE602005017626D1 DE602005017626T DE602005017626T DE602005017626D1 DE 602005017626 D1 DE602005017626 D1 DE 602005017626D1 DE 602005017626 T DE602005017626 T DE 602005017626T DE 602005017626 T DE602005017626 T DE 602005017626T DE 602005017626 D1 DE602005017626 D1 DE 602005017626D1
Authority
DE
Germany
Prior art keywords
acid complexes
borinic acid
antiviral use
antiviral
borinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005017626T
Other languages
German (de)
English (en)
Inventor
Carolyn Bellinger-Kawahara
Kirk R Maples
Jacob J Plattner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anacor Pharmaceuticals LLC
Original Assignee
Anacor Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals LLC filed Critical Anacor Pharmaceuticals LLC
Publication of DE602005017626D1 publication Critical patent/DE602005017626D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005017626T 2004-06-14 2005-06-14 Antivirale verwendung von borinsäurekomplexen Expired - Lifetime DE602005017626D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14
PCT/US2005/020978 WO2006085932A2 (en) 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes

Publications (1)

Publication Number Publication Date
DE602005017626D1 true DE602005017626D1 (de) 2009-12-24

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017626T Expired - Lifetime DE602005017626D1 (de) 2004-06-14 2005-06-14 Antivirale verwendung von borinsäurekomplexen

Country Status (12)

Country Link
US (1) US7393856B2 (enExample)
EP (1) EP1765360B1 (enExample)
JP (1) JP2008502694A (enExample)
AT (1) ATE447960T1 (enExample)
BR (1) BRPI0512049A (enExample)
CA (1) CA2570577A1 (enExample)
DE (1) DE602005017626D1 (enExample)
ES (1) ES2333244T3 (enExample)
MX (1) MXPA06014417A (enExample)
PT (1) PT1765360E (enExample)
TW (1) TW200612967A (enExample)
WO (1) WO2006085932A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006332797A1 (en) * 2005-12-28 2007-07-12 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
BRPI0708051A2 (pt) 2006-02-16 2011-05-17 Anacor Pharmaceuticals Inc moléculas pequenas contendo boro como agentes antiflamatórios
JP5606913B2 (ja) * 2008-08-11 2014-10-15 独立行政法人科学技術振興機構 蛋白質架橋阻害剤
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
UY35287A (es) 2013-01-30 2014-08-29 Dow Agrosciences Llc Uso de benzoxaborolas como agentes antimicrobianos volátiles en carnes, plantas o partes de plantas.
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
KR101756785B1 (ko) 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
EP3426029B1 (en) 2016-03-07 2023-08-30 AgroFresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
TWI883391B (zh) * 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5788800A (en) 1999-07-07 2001-01-22 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
EP1581500A4 (en) 2002-12-18 2008-03-05 Anacor Pharmaceuticals Inc ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHODS OF USE

Also Published As

Publication number Publication date
TW200612967A (en) 2006-05-01
EP1765360A2 (en) 2007-03-28
CA2570577A1 (en) 2006-08-17
EP1765360B1 (en) 2009-11-11
JP2008502694A (ja) 2008-01-31
BRPI0512049A (pt) 2008-02-06
WO2006085932A2 (en) 2006-08-17
US7393856B2 (en) 2008-07-01
WO2006085932A3 (en) 2006-10-05
ATE447960T1 (de) 2009-11-15
PT1765360E (pt) 2009-12-24
ES2333244T3 (es) 2010-02-18
HK1102702A1 (en) 2007-11-30
MXPA06014417A (es) 2007-03-08
US20060019927A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
EA200802213A1 (ru) Способы лечения заболеваний крови
DE602005017626D1 (de) Antivirale verwendung von borinsäurekomplexen
EA201100390A1 (ru) Соединения для лечения гепатита с
CY1110084T1 (el) Χρηση συμπυκνωμενων ετεροκυκλικων ενωσεων ως αναστολεις scce για την θεραπευτικη αγωγη δερματικων ασθενειων
NO20070782L (no) Tetrapeptidanaloger.
DE50310516D1 (de) Fredericamycin-derivate
EA200701114A1 (ru) Азоловые производные с антимускариновой активностью
CY1112383T1 (el) Αναστολεις της πρωτεϊνης ενεργοποιησης της 5-λιποξυγενασης (flap)
NO20060664L (no) N-substituerte benzimidazolyl C-kit inhibitorer
DK1558616T4 (da) Meso-substituerede porphyriner
EA200501771A1 (ru) Лиганды каннабиноидных рецепторов и их применения
BR0207811A (pt) Compostos de uréia aril e heteroaril substituìdos úteis no tratamento de doenças
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
ATE448232T1 (de) Substituierte heterozyklen
TW200509892A (en) Novel aminobenzophenone compounds
BR0310055A (pt) Derivados de piridinacarboxamida pesticidas
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
ATE445406T1 (de) Verwendung von eisen(iii)-komplexverbindungen
SE0300457D0 (sv) Novel compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition